Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Michele Hu speaks at the Annual Parkinson's UK Flagship Lecture at the Royal Institution.

On 6 November 2014 Dr Michele Hu from the Nuffield Department of Clinical Neurosciences and Dr Alistair Noyce from UCL gave presentations about the search for biomarkers, stratification and how this could lead to more bespoke treatments for Parkinson’s.

The speakers were joined by the newly appointed Parkinson's UK Director of Research and Innovation, Dr Arthur Roach, for a Q&A session after the talks. Colin Cheesman, a Parkinson's UK trustee, gave closing remarks.

The lecture was attended by around 300 people, largely those affected by Parkinson's but also students and other supporters of the charity. 

Read more about our work on Parkinson's and other movement disorders.

 

“Thank you so much for a fascinating evening yesterday. It was really exciting to hear what kind of projects our fund raising is supporting. All the speakers were excellent and took great trouble to make the talks clear and informative and the final speaker giving a patient's view was very moving.”
- Event attendee

 

 

Similar stories

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.

New insights gained into how the brain encodes information about the world

Scientists have developed a new way to test the theory that active neurons can change what they signal in the world, rather than keeping a stable correspondence to things (such as a features of an object, or ideas).

Oxford and Quinnipiac researchers discuss integrated clinical care, education, and research in multiple sclerosis

Mount Sinai Rehabilitation Hospital's Mandell Center for Multiple Sclerosis Care and Neuroscience Research welcomed University of Oxford partners in September. Stakeholders from University of Oxford and Quinnipiac University met to discuss ongoing research and future opportunities to develop a Mandell MS Center concept of care in the UK.

Repurposed drug could help patients with motor neuron disease

A drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND), according to a new study.

Finding out more about Parkinson’s by monitoring symptoms at home

Professor Chrystalina Antoniades explains how the COVID pandemic accelerated an innovation in one research project into Parkinson's Disease.